Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000248560

Medchemexpress LLC 6-[3,4-dihydroxy-pyrrolid-1-yl]-2-[3-hydroxy-3-methyl-pyrrolid-1-yl]-4-(CF3)pyridine-3-carbonitrile | 2135304-43-5 | 99.1% | 372.34 g·mol⁻1 | C16H19F3N4O3 | 100 MG
SDP

Catalog No. 5000248560
Encompass_Preferred

KHK-IN-2 is a potent and selective ketohexokinase (KHK) inhibitor with a reported IC50 of 0.45 μM, supplied as a high-purity small-molecule research compound suitable for enzymatic, cell-based, and in vivo studies.

  • Potent KHK inhibition with IC50 0.45 μM.
  • High purity, approximately 99.05% by COA.
  • Highly soluble in DMSO (stock solutions up to 250 mg/mL).
  • Formulation guidance provided for in vivo dosing.
  • Powder storage: -20°C (3 years) or 4°C (2 years); in solvent: -80°C (2 years).
  • Datasheet, COA, SDS, and LCMS documentation available for verification.

Catalog No. 50-002-48560 Supplier Medchemexpress LLC Supplier No. HY103478100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

KHK-IN-2 is a potent and selective ketohexokinase (KHK) inhibitor with a reported IC50 of 0.45 μM, supplied as a high-purity small-molecule research compound suitable for enzymatic, cell-based, and in vivo studies.

  • Potent KHK inhibition with IC50 0.45 μM.
  • High purity, approximately 99.05% by COA.
  • Highly soluble in DMSO (stock solutions up to 250 mg/mL).
  • Formulation guidance provided for in vivo dosing.
  • Powder storage: -20°C (3 years) or 4°C (2 years); in solvent: -80°C (2 years).
  • Datasheet, COA, SDS, and LCMS documentation available for verification.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.